Sources | Names Used |
---|---|
CTRPv2 | salermide:PLX-4032 (12:1 mol/mol) |
PharmacoGx | salermide:PLX-4032 (12:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF516 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ZNF582 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | ZNF585A | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | ZNF596 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
mRNA | ZNF618 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | ZNF654 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
mRNA | ZNF658 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | ZNF665 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
mRNA | ZNF697 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-06 |
mRNA | ZNF704 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |